Accordingly, we speculate that E2F1 may affect the progression and prognosis of various diseases such as asthma, malignant tumor through basal transcriptional regulation of human ADRB2 gene, and that E2F1 may become a new therapeutic target and prognostic marker. This evidence concerns the gene E2F1 and asthma.